Primary prevention of early postoperative right ventricular failure: clinical experience with the use of levosimendan before implantation of a left ventricular assist device

Early right ventricular failure after left ventricular assist device (LVAD) implantation is one of the main causes of a worse postoperative prognosis. The problem of de novo right ventricular failure requires the search for methods of primary prevention and improvement of treatment strategies in its development. Preoperative therapy with levosimendan has a positive effect on right ventricular function and may be considered as a method of preoperative preparation for LVAD implantation.